Yang CP - Search Results

1

Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.

Smith AB, Sugasawa K, Atasoylu O, Yang CP, Horwitz SB. Smith AB, et al. Among authors: yang cp. J Med Chem. 2011 Sep 22;54(18):6319-27. doi: 10.1021/jm200692n. Epub 2011 Aug 26. J Med Chem. 2011. PMID: 21870795 Free PMC article.

2

Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells.

Shahabi S, Yang CP, Goldberg GL, Horwitz SB. Shahabi S, et al. Among authors: yang cp. Gynecol Oncol. 2010 Nov;119(2):345-50. doi: 10.1016/j.ygyno.2010.07.005. Epub 2010 Aug 2. Gynecol Oncol. 2010. PMID: 20674962 Free PMC article.

3

Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.

Khrapunovich-Baine M, Menon V, Yang CP, Northcote PT, Miller JH, Angeletti RH, Fiser A, Horwitz SB, Xiao H. Khrapunovich-Baine M, et al. Among authors: yang cp. J Biol Chem. 2011 Apr 1;286(13):11765-78. doi: 10.1074/jbc.M110.162214. Epub 2011 Jan 18. J Biol Chem. 2011. PMID: 21245138 Free PMC article.

4

Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.

Wiesen KM, Xia S, Yang CP, Horwitz SB. Wiesen KM, et al. Among authors: yang cp. Cancer Lett. 2007 Nov 18;257(2):227-35. doi: 10.1016/j.canlet.2007.07.022. Epub 2007 Sep 14. Cancer Lett. 2007. PMID: 17869412

5

The interaction between mitotic checkpoint proteins, CENP-E and BubR1, is diminished in epothilone B-resistant A549 cells.

Yang CP, Liu L, Ikui AE, Horwitz SB. Yang CP, et al. Cell Cycle. 2010 Mar 15;9(6):1207-13. doi: 10.4161/cc.9.6.11122. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237434

6

Eribulin disrupts EB1-microtubule plus-tip complex formation.

O'Rourke B, Yang CP, Sharp D, Horwitz SB. O'Rourke B, et al. Among authors: yang cp. Cell Cycle. 2014;13(20):3218-21. doi: 10.4161/15384101.2014.950143. Cell Cycle. 2014. PMID: 25485501 Free PMC article.

7

Proteomics of cancer cell lines resistant to microtubule-stabilizing agents.

Albrethsen J, Angeletti RH, Horwitz SB, Yang CP. Albrethsen J, et al. Among authors: yang cp. Mol Cancer Ther. 2014 Jan;13(1):260-9. doi: 10.1158/1535-7163.MCT-13-0471. Epub 2013 Nov 19. Mol Cancer Ther. 2014. PMID: 24252851 Free PMC article.

8

Gene expression and mitotic exit induced by microtubule-stabilizing drugs.

Chen JG, Yang CP, Cammer M, Horwitz SB. Chen JG, et al. Among authors: yang cp. Cancer Res. 2003 Nov 15;63(22):7891-9. Cancer Res. 2003. PMID: 14633718

9

Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells.

Yang CP, Horwitz SB. Yang CP, et al. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):76-83. doi: 10.1016/s0167-4889(02)00200-8. Biochim Biophys Acta. 2002. PMID: 12063170 Free article.

10

A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence.

Yang CP, Verdier-Pinard P, Wang F, Lippaine-Horvath E, He L, Li D, Höfle G, Ojima I, Orr GA, Horwitz SB. Yang CP, et al. Mol Cancer Ther. 2005 Jun;4(6):987-95. doi: 10.1158/1535-7163.MCT-05-0024. Mol Cancer Ther. 2005. PMID: 15956256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters